Attached files
file | filename |
---|---|
10-K/A - FORM 10-K AMENDMENT - Vaxart, Inc. | d262743d10ka.htm |
Exhibit 31.1
Nabi Biopharmaceuticals
CERTIFICATIONS
I, Raafat E.F. Fahim, certify that:
1. I have reviewed this annual report on Form 10-K/A of Nabi Biopharmaceuticals;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
Date: April 30, 2012 | By: | /s/ Raafat E.F. Fahim, Ph.D. | ||
Raafat E.F. Fahim, Ph.D. Chief Executive Office, President and Acting Chief Financial Officer |